Data Characteristics
Peptide drug data originates from drug development reports, clinical trial documents, patent literature, academic papers, and pharmacopoeia standards. These documents typically contain peptide sequences, structural formulas, mechanisms of action, pharmacokinetic parameters, toxicology data, indications, contraindications, and preparation processes. Data updates are infrequent, occurring mainly during new drug approvals, clinical data releases, or patent expirations. Documents are primarily semi-structured text, often including numerous chemical names, biological terms, and experimental data tables. For fields and units, peptide sequences use amino acid abbreviations. Molecular weights use Da or kDa. Concentrations use μM or mg/mL. Half-lives use hours or days.
Constraints on Knowledge Base Retrieval
Specialized terminology and sequence information in peptide drug data challenge traditional text retrieval, requiring more precise semantic understanding. Table data in semi-structured documents can lead to critical numerical information loss if not parsed effectively. Infrequent data updates mean knowledge base construction must prioritize historical data completeness and include regular incremental updates. Documents are long and contain extensive specialized details. A single segment may not fully express all characteristics of a peptide drug, requiring consideration of cross-paragraph and cross-document relationships. Heterogeneous peptide drug names (generic names, trade names, research codes) also increase retrieval complexity, necessitating multi-dimensional indexing strategies.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Segment Length | 800–1200 characters | Balances the completeness of peptide drug descriptions with the focus of a single segment, preventing key information truncation. |
Segment Overlap Length | 100–150 characters | Ensures contextual continuity, especially when processing specialized terms or sequence information across paragraphs. |
Recall Count | Top 5–8 items | Considering the complexity of peptide drug information, increasing the recall count helps cover more relevant aspects. |
Similarity Threshold | Calibrate by measurement | Determine experimentally based on the specific embedding model and dataset to balance recall and precision, for example, 0.75. |
Rerank Return Count | Top 3 items | After optimization by the rerank model, focus on the most relevant results to improve user experience. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Peptide drug development reports or patent files can be lengthy, requiring longer parsing times. |
Common Pitfalls
- Symptom: Retrieval results contain many irrelevant general biological concepts, failing to pinpoint specific peptide drugs. Reason: The knowledge base segmentation did not effectively distinguish between general background knowledge and core drug information, leading to generalized recall.
- Symptom: When users query for a specific peptide's molecular weight or half-life, the returned content lacks specific numerical values. Reason: Document parsing failed to accurately identify and extract numerical fields from tables or structured text, treating them as plain text.
- Symptom: After local deployment, multiple queries for the same question yield highly fluctuating results. Reason: This may be due to a high
temperatureparameter in the local model configuration or not enabling a strategy to strictly reply based on knowledge base content.
Verification Steps
- For different query intents (e.g., "mechanism of action of XX peptide", "clinical indications of XX peptide"), verify that the recalled segments accurately contain core information.
- Randomly select key numerical values from peptide drug data (e.g., molecular weight
1500 Da), query the knowledge base, and check if the returned results accurately present these values. - Use queries containing peptide sequences or complex chemical structures. Verify if the retrieval results can identify and match relevant document snippets.
- Simulate user questions. Check if the model, in strict mode, answers only based on knowledge base content, avoiding fabricated information.
The values provided are common starting points. Measure them against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.